Search
Absci Corp
ABSIAdd to Watchlist
9.100USD
0.0000.00%
Close 08-14 16:00（ET）Quotes delayed by 15 min
1.56BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Absci Corp is 8.20, ranking 159 out of 387 in the Biotechnology & Medical Research industry. The average price target is 9.00, with a high of 10.00 and a low of 5.80.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
13.875
Target Price
+51.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Absci Corp
ABSI
10
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Absci Corp's expected revenue for the next quarter?
Absci Corp's expected revenue is 1.29M.
What is Absci Corp's price target?
Analysts forecast that Absci Corp's price target is USD 9.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 5.80.
How have Absci CorpABSI's recent earnings per share performed?
The market expectation was USD -0.21, while Absci CorpABSI's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.21.
What is the analyst rating for Absci Corp?
Based on the ratings of Absci Corp's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.